Schizophrenia Drug
Sort by
9 items
-
Financial Times - Business
General Atlantic nears £800mn deal to buy UK’s Learning Technologies
London-based group is ‘minded to recommend’ the 100p per share offer from private equity group1 hour ago -
Financial Times - Business
WeightWatchers chief executive leaves as company grapples with impact of anti-obesity drugs
Sima Sistani leaves despite effort to transform group into online prescriber1 hour ago -
Financial Times - Business
Everyone’s on Ozempic. So why will no one talk about it?
The fashion world is embracing weight-loss drugs — discreetly4 hours ago -
MarketWatch - Business
Bristol-Myers Squibb stock jumps on schizophrenia drug approval
Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia drug.8 hours ago -
ABC News - Top stories
FDA approves 1st new drug to treat schizophrenia in more than 30 years
The FDA on Thursday approved the first new drug to treat patients with schizophrenia in more than 30 years.17 hours ago - FDA -
CNBC - Business
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia.18 hours ago - FDA -
The New York Times - Health
F.D.A. Approves a New Antipsychotic Drug
Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.18 hours ago -
-
CNBC - Business
Trump ally Matt Gaetz says House Ethics panel issued subpoena for him in sex, drug probe
Florida Republican Rep. Matt Gaetz, a close Donald Trump ally, said he will no longer comply with an ethics investigation into sex and drug use allegations.20 hours ago - Donald Trump